Erik Jensen, MD and Thomas H. Shaffer, MSE, PhD
In this segment, “Classification of BPD Using Clinically Relevant Outcomes,” Dr. Thomas Shaffer and Dr. Erik Jensen present insight into a new classification of bronchopulmonary dysplasia (BPD).
The classification system for BPD has been revised throughout the years since being first defined in the 1960s. Historically, BPD has been defined by its treatment modalities. As the population of infants who develop BPD now includes sicker, more premature infants who rely on newer treatment modalities, it may be important to alter our definition in order to better predict and describe their long term outcomes. Dr. Jensen’s group proposes a new classification of BPD that utilizes not only consensus but also outcome data to create a grading system of BPD. Importantly, patients are cohorted based on need for invasive versus noninvasive ventilation irrespective of FiO2 requirement. This new classification has been shown to better predict clinically meaningful respiratory and neurologic morbidity and long-term neonatal outcomes.